Position in ERAS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$51,879,803
+$6,065,519 QoQ
Shares Held
2,831,867
+0.0% QoQ
Ownership
0.810%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#22
of 257 holders
Holding Since
Sep 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ERAS ranks #25 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in ERAS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,879,803 | 2,831,867 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $45,814,284 | 2,831,538 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,181,988 | 1,930,642 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,344,970 | 1,534,390 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,634,475 | 2,074,390 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,681,983 | 4,147,433 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,409,660 | 4,147,275 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,299,057 | 4,138,849 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,756,324 | 4,134,036 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,835,033 | 890,793 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,957,723 | 919,119 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $243,438 | 123,573 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $341,061 | 123,573 | Shares | Sole | 2023-08-14 | |
| 2022-06-30 | $2,017,153 | 362,146 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,940,081 | 458,149 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,388,890 | 410,070 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,702,173 | 410,093 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||